On January 12, 2026, Freenome announced an expansion of its successful collaboration with NVIDIA, bringing artificial intelligence to early cancer detection.
See the press release here. See the Freenome Linked In posting, where you can track real-time comments and feedback.
Freenome was featured in NVIDIA's "Healthcare Diagnostics Industry Brief" a couple months back - here. See the 9 page PDF white paper here. [Highlights from Freenome, Natera, Guardant, Sofia,
###
AI writes in brief:
- Freenome announced a major expansion of its AI partnership with NVIDIA to speed up and improve the accuracy of its blood-based multi-cancer screening tests, using GPU-accelerated deep learning to analyze cfDNA, methylation, RNA, and protein signals at massive scale.
- The collaboration will support both Freenome’s proprietary fragment-level deep learning models and a new open-source cfDNA methylation foundation model, as the company prepares for FDA review of its first colorectal cancer test and multiple new launches in 2026.
##
